ArticleOpen forum infectious diseases2023

Product Choice Affects Risk of False-Positive Hepatitis B Virus Serology During Immunoglobulin Replacement Therapy.

Hannes Lindahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.